leisure time -WSS

leisure time

author：hotspot 2025-10-02 18:05:39 - browse：96585

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Medicare innovation center doesn’t save money, experts say

WSS

Study points to new risk in gene therapy death of Terry Horgan

What it's like to live with paralysis for one psychologist

The United States is paying nearly triple for new Covid vaccines

The haunting brain science of long Covid

Roche’s Alnylam deal shows drug firms interested in heart drugs

'Investigate these claims': UFO transparency at center of House hearing

focus

leisure time

entertainment

Sports medicine is finally prioritizing gender equality

New oral drug delivery patch is modeled after octopus tentacles

Tori Bowie and the unacceptable rates of Black maternal death

Why patients can’t get everything they want on drug pricing

Heart attack and stroke risk calculators need revising

CDC Director Mandy Cohen on transparency, trust, and health

Anesthesiologist group: stop taking Ozempic before surgery

Stop Congress from blocking public access to science

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden warns of ‘dark winter’ during final presidental debate

Wikipedia

Dems pitch expanding Medicare power to negotiate drug prices

Congress extends some pandemic preparedness programs

2023 Nobel Prize in Medicine goes to Karikó and Weissman

CDC Director Mandy Cohen on transparency, trust, and health

6 solutions to address cancer drug shortages and others

2023 Nobel Prize in Medicine goes to Karikó and Weissman

explore

hotspot

focus

focus